Peptogen

Peptogen is a Brazilian biotechnology company specializing in the development and production of recombinant peptides and proteins for the pharmaceutical industry. Founded in 2005 and later acquired by the Cristália Group, the company operates a state-of-the-art facility dedicated to high-complexity biological synthesis. Its portfolio includes active pharmaceutical ingredients (APIs) such as somatropin, glucagon, and teriparatide. Peptogen plays a critical role in Brazil's biopharmaceutical landscape by reducing dependence on imported biological raw materials. The company focuses on scaling up laboratory processes to industrial production while maintaining strict GMP standards.